#Vacc-iNTS Consortium wishes you Happy Holiday Season and New Year! vacc-ints.eu

It's #WorldNTDDay. NTDs are high on ITM's agenda & our researchers are working on a clinical, epidemiological and biomedical level, through fundamental & applied research. We need a hands-on mentality and a strong sense of global solidarity to #BeatNTDs. itg.be/E/Article/30-j…

ECCMID 2021 New dates: the 31st ECCMID will take place from Friday, 9 July to Monday, 12 July 2021 in Vienna, Austria.

🆕 Applications now open‼️‼️ We are pleased to announce that Master in Vaccinology💉 and Drug Development 💊academic year 2020-2021 is now #open for #applications up to September 30, 2020 at 11:59PM italian time. ✅ ifgh.org/educational-pr… Università di Siena

Today is the day: very happy to virtually meet all Partners at the first Vacc-iNTS annual meeting!

Yep, true story. Invasive non-typhoidal Salmonella remains an unrecognised killer .... But iNTS, we see you & we're comin' after ya ... vaccines are on the horizon and we're gearing up #Malawi Vacc-iNTS project @MlwTrust

Registration is still open for the 10th EDCTP Forum on Equality in Research for Health!

🗓️The Vacc-iNTS 2021 Annual Meeting will take place today and tomorrow. 🌍Happy to meet all Partners! #vaccintsannualmeeting #H2020

The 12th International Conference on #Typhoid & Other Invasive Salmonelloses is going virtual on Dec 6-8, 2021! Learn more + register here: typhoid2021.org #Typhoid2021

👉Do you want to learn more about complications and mortality of the iNTS disease? 🌍Proud to share this review! This study received funding from the European Union's Horizon 2020 research and innovation program (grant agreement No 815439). #vaccintsproject #openaccess #H2020

Could you help investigate a new vaccine? You are invited to take part in a study to investigate an invasive non-Typhoid Salmonella (iNTS) disease. The study is being run by the Oxford Vaccine Group & would not be possible without Vacc-iNTS project ➡️bit.ly/3Qc6OsK

#News for #investors & #media Invasive non-typhoidal Salmonella disease can be life-threatening for children in Africa and a key driver of #AMR. We're using our GMMA technology and partnering with University of Oxford Oxford Vaccine Group Vacc-iNTS project to explore a potential candidate vaccine.

Help us prevent a neglected infectious disease. We will provide reimbursement, up to a maximum of £585, for your time, inconvenience and travel. The total study participation time is 12 months. Join our study and help us make a difference to millions.🔻 Vacc-iNTS project

Help us prevent blood poisoning in children under 5 years of age in sub-Saharan Africa. 𝐓𝐡𝐞 𝐒𝐀𝐋𝐕𝐎 𝐓𝐫𝐢𝐚𝐥: 𝐓𝐡𝐞 𝐟𝐢𝐫𝐬𝐭 𝐞𝐯𝐞𝐫 𝐯𝐚𝐜𝐜𝐢𝐧𝐞 𝐟𝐨𝐫 𝐢𝐍𝐓𝐒 Join our study and help us make a difference to millions.🔻 trials.ovg.ox.ac.uk/trials/salvo Vacc-iNTS project

Today the Vacc-iNTS Consortium is meeting in Siena (Italy) for the 2023 annual meeting to discuss the progress on the activities for the advancement of the development on a novel vaccine against #iNTS and recent results of the different work packages will be presented.

🎉 The time has come 🎉 We are more than excited to invite you to #IUMS2024: ‘Microbiological adaptation in times of ecological disturbance and disruption’ 🦠 💚 Save The Date 💚 📆 23-25 October 2024 ➡️ Subscribe to be the first to learn all updates: iums2024.com

⌛️Final few hours to register for the VSV-EBOPLUS Open Conference on “Systems analysis of adult and pediatric responses to the VSV-ZEBOV Ebola vaccine” virtually happening at 3:00-6:00 p.m. CEST🎯 Info to sign up ➡️ hipaa.jotform.com/230363917722052

👉bmjopen.bmj.com/content/13/11/…

Team Malawi in our Salmonella-happy-place, enjoying hanging with our favourite #Salmonella pals from all over the world in Rwanda. Exciting progress being reported, and even more possibilities ahead for tackling #iNTS and #typhoid. Vacc-iNTS project Take on Typhoid #VaccinesWork

🚨 Exciting update from Siena, Italy! 🚨 👉🏻The Vacc-iNTS Consortium is gathering today for the 2025 annual meeting to discuss progress on the development of a novel vaccine against #iNTS. Recent results from the various work packages will be presented 🎯